Taiwan FDA registration cd10558e5ba0085168439918a640c18b

Brahms mid-segment anterior atrial natriuretic test set

TW: 布拉姆斯中段前心房利鈉呔檢驗試劑組

Taiwan·Risk Class 2·B.R.A.H.M.S GmbH·Registered May 10, 2012 – May 10, 2027Active

Registration details

Analysis ID: cd10558e5ba0085168439918a640c18b
Customs Code: DHA00602353207

Company information

Manufacturer: B.R.A.H.M.S GmbH
Manufacturer Country: Germany
Authorized Representative: MEDTRI CO., LTD.

Product details

Intended Use: Quantitatively detect mid-anteroatrial natriuretic peptide (MR-proANP) in human serum or plasma (containing EDTA or heparin) with B.R.A.H.M.S KRYPTOR/KRYPTOR compact/KRYPTOR Compact PLUS analyzer.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1117 B type B natriuretic peptide test system
Import Information: import

Dates and status

Registration Date: May 10, 2012
Expiry Date: May 10, 2027

About this record

Access comprehensive regulatory information for Brahms mid-segment anterior atrial natriuretic test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cd10558e5ba0085168439918a640c18b and manufactured by B.R.A.H.M.S GmbH. The authorized representative in Taiwan is MEDTRI CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.